Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Cabazitaxel in mCRPC Patients With AR-V7 Positive Circulating Tumor Cells (CTCs) (CABA-V7)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03050866
Recruitment Status : Recruiting
First Posted : February 13, 2017
Last Update Posted : August 7, 2018
Sponsor:
Collaborator:
Sanofi
Information provided by (Responsible Party):
M.P.J.K. Lolkema, Erasmus Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : February 2019
  Estimated Study Completion Date : February 2020